Membrane fluidity in human and mouse Chediak-Higashi leukocytes

Area of Science:

• Cell Biology
• Biophysics
• Immunology

Background:

• Chediak-Higashi syndrome is a rare genetic disorder affecting immune cells.
• Previous studies indicated microtubule assembly defects in Chediak-Higashi cells.
• The role of cell membrane properties in this syndrome was unclear.

Purpose of the Study:

• To investigate cell membrane fluidity in Chediak-Higashi syndrome.
• To explore potential therapeutic interventions targeting membrane properties.

Main Methods:

• Utilized spin label electron spin resonance spectrometry to analyze membrane fluidity.
• Characterized polymorphonuclear leukocytes from human and mouse models of Chediak-Higashi syndrome.
• Assessed the effects of in vitro treatments including ascorbate, glucose oxidase, and cyclic guanosine monophosphate.

Main Results:

• Chediak-Higashi cells displayed significantly increased membrane fluidity compared to normal controls.
• In vitro ascorbate and glucose oxidase treatments normalized membrane order parameters.
• Catalase abolished the effect of glucose oxidase, implicating reactive oxygen species.
• Dibutyryl cyclic guanosine monophosphate did not affect membrane fluidity.

Conclusions:

• Increased cell membrane fluidity is a characteristic defect in Chediak-Higashi syndrome.
• Oxidation-reduction potential influences membrane fluidity in these cells.
• Membrane fluidity abnormalities appear to be a distinct defect from microtubule dysfunction in Chediak-Higashi syndrome.